POLYPEPTIDE UND VERWENDUNGEN DAVON

Patent europeic · EP4263586 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4263586
Numer da la dumonda
EP21839935
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
15-12-2021
Publitgà
25-10-2023
Concedì
11-03-2026
La protecziun finescha il pli tard
14-12-2041
Proxima taxa annuala scadenta
31-12-2026
Classas IPC
C07K 14/575 (2006.01)
A61P 3/10 (2006.01)
A61P 3/08 (2006.01)
Prioritad
US 202063125996 P 16.12.2020
Dumonda PCT
PCT/EP2021/086034 15.12.2021
Publicaziun PCT
WO2022/129254 23.06.2022
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 02-06-2026

    Represchentant inscrit

    Representative
    Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 02.06.2026

  2. 11-03-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 11.03.2026

Partidas

Possessur

Medimmune Limited

MedImmune Limited

1 Francis Crick Avenue Cambridge Biomedical Campus, Cambridge CB2 0AA, GB

Represchentant

Novagraaf International SA

Chemin de l'Echo 3, 1213 Onex

Inventur

BEDNAREK, Maria Aleksandra

Cambridge Cambridgeshire CB21 6GH, GB

GENAPATHY, Sivaneswary

Cambridge Cambridgeshire CB21 6GH, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.